Skip to content

Sera Prognostics SERA Investment Purchases

Investment Purchases at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$6.7M-95.7%
Personalis, Inc. logo
Personalis, Inc.PSNL
$67.04M+4.3%
Progyny logo
ProgynyPGNY
$0-100%
Pediatrix Medical Group logo
Pediatrix Medical GroupMD
$7.01M-9.7%

Other financials

Income statement

See full
Revenue$14.0K-63.2%
Operating income-$9.4M-1.2%
Net income-$8.4M-2.6%
EPS (diluted)-$0.17+15.0%

Balance sheet

See full
Cash & equivalents$4.2M-20.2%
Total debt$2.5M+286%
Total equity$67.6M-28.7%
Total assets$93.5M-20.8%

Cash flow

See full
Operating cash flow-$8.8M-16.2%
CapEx$8.0K+167%
Free cash flow-$8.8M-16.2%

Valuation

See full
Market cap$71.27M+5.0%
Enterprise value$69.6M+9.6%
P/S1,250.3×+622×

Profitability

See full
Operating margin-64,235.1%-8,092,342pp
Net margin-56,386%+1,586,573pp
FCF margin-48,377.2%-673,104pp

Returns & leverage

See full
Return on equity-39.6%-1.6pp
Debt / equity0.0×
Current ratio2.1×+0.1×

Where this comes from

Reported directly by Sera Prognostics in its filing.

Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.

The official record: Sera Prognostics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sera Prognostics's investment purchases.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sera Prognostics's investment purchases?
Sera Prognostics (SERA) reported investment purchases of $1.01M in Q1 2026.
How has Sera Prognostics's investment purchases changed year-over-year?
Sera Prognostics's investment purchases decreased by 98.2% year-over-year, from $56.57M to $1.01M.
What is the long-term trend for Sera Prognostics's investment purchases?
Over 4 years (2021 to 2025), Sera Prognostics's investment purchases has grown at a 1.7% compound annual growth rate (CAGR), from $82.06M to $87.61M.
What does investment purchases mean?
Cash spent purchasing investment securities across all categories.